These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28380046)

  • 1. Structural features embedded in G protein-coupled receptor co-crystal structures are key to their success in virtual screening.
    Coudrat T; Christopoulos A; Sexton PM; Wootten D
    PLoS One; 2017; 12(4):e0174719. PubMed ID: 28380046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the Modeling of Extracellular Ligand Binding Pockets in RosettaGPCR for Conformational Selection.
    Liessmann F; Künze G; Meiler J
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey.
    Kratochwil NA; Gatti-McArthur S; Hoener MC; Lindemann L; Christ AD; Green LG; Guba W; Martin RE; Malherbe P; Porter RH; Slack JP; Winnig M; Dehmlow H; Grether U; Hertel C; Narquizian R; Panousis CG; Kolczewski S; Steward L
    Curr Top Med Chem; 2011; 11(15):1902-24. PubMed ID: 21470172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
    Kumari P; Ghosh E; Shukla AK
    Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J; Kling RC; Gmeiner P; Löber S
    Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Use of GPCR Modeling and SDM Experiments to Understand Ligand Binding.
    Potterton A; Heifetz A; Townsend-Nicholson A
    Methods Mol Biol; 2018; 1705():335-343. PubMed ID: 29188570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-optimized homology models of D₁ and D₂ dopamine receptors: application for virtual screening.
    Kołaczkowski M; Bucki A; Feder M; Pawłowski M
    J Chem Inf Model; 2013 Mar; 53(3):638-48. PubMed ID: 23398329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function-specific virtual screening for GPCR ligands using a combined scoring method.
    Kooistra AJ; Vischer HF; McNaught-Flores D; Leurs R; de Esch IJ; de Graaf C
    Sci Rep; 2016 Jun; 6():28288. PubMed ID: 27339552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
    Heifetz A; James T; Southey M; Morao I; Fedorov DG; Bodkin MJ; Townsend-Nicholson A
    Methods Mol Biol; 2020; 2114():163-175. PubMed ID: 32016893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity.
    Jaiteh M; Rodríguez-Espigares I; Selent J; Carlsson J
    PLoS Comput Biol; 2020 Mar; 16(3):e1007680. PubMed ID: 32168319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of water and protein flexibility in the structure-based virtual screening of allosteric GPCR modulators: an mGlu
    Orgován Z; Ferenczy GG; Keserű GM
    J Comput Aided Mol Des; 2019 Sep; 33(9):787-797. PubMed ID: 31542869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling and Deorphanization of Orphan GPCRs.
    Diaz C; Angelloz-Nicoud P; Pihan E
    Methods Mol Biol; 2018; 1705():413-429. PubMed ID: 29188576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.
    Cross JB
    Methods Mol Biol; 2018; 1705():233-264. PubMed ID: 29188566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures of G protein-coupled receptors reveal new opportunities for drug discovery.
    Cooke RM; Brown AJ; Marshall FH; Mason JS
    Drug Discov Today; 2015 Nov; 20(11):1355-64. PubMed ID: 26303408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise.
    Yarnitzky T; Levit A; Niv MY
    Curr Opin Drug Discov Devel; 2010 May; 13(3):317-25. PubMed ID: 20443165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From three-dimensional GPCR structure to rational ligand discovery.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    Adv Exp Med Biol; 2014; 796():129-57. PubMed ID: 24158804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-based lead discovery on G-protein-coupled receptors.
    Visegrády A; Keserű GM
    Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
    Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
    Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.